Abstract
Vascular endothelial growth factor (VEGF) has emerged as a key mediator of angiogenesis and macular edema in ocular diseases such as neovascular macular degeneration, vein occlusions, and diabetic retinopathy.1,2 Therapies to neutralize VEGFs action in ocular diseases have been used to successfully combat VEGFs pathogenic role in the eye.
Original language | English (US) |
---|---|
Title of host publication | Retinal Angiography and Optical Coherence Tomography |
Publisher | Springer New York |
Pages | 279-288 |
Number of pages | 10 |
ISBN (Print) | 9780387689869 |
DOIs | |
State | Published - Dec 1 2009 |
ASJC Scopus subject areas
- Medicine(all)